ERA COBIOTECH - A NEW ERA NET COFUND ON BIOTECHNOLOGY - DR. PETRA E. SCHULTE/DR. CHRISTIAN BREUER
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
ERA CoBioTech – a new ERA Net Cofund on Biotechnology Dr. Petra E. Schulte/Dr. Christian Breuer Project Management Jülich (JUELICH) Division Bioecomony Department European Initiatives, International Affairs (BIO7) Forschungszentrum Jülich GmbH
Call promotion
Issues for the preparation of call launch
CoBioTech aims to provide biotechnology stakeholders with tailor-
made support regarding
information, communication, networking and
research funding
Joint funding activities
Training for scientists and funders
European BioTech Hub
Strategy
Societal challenges in the 21st century
• Increasing world population and
changes in food utilisation
patterns
• Increase of food associated
diseases
• Climate change/protection,
resource conservation/protection
• Need for a sustainable energy
production
• Transfer from a fossil to a bio-
based raw material supply
Knowledge-based Bioeconomy – Vision and Objectives
Germany pursues the vision of a
natural,
cycle-oriented,
sustainable biobased economy
that carries the promise of
global food supplies that are both
ample and healthy,
and of high quality products from
renewable resources.
meet our responsibilities for global nutrition, the protection of the climate,
efficient use of resources and the environment
What is a Bioeconomy?
Consumer Production
• socio-economics • agri-tech
• logistics • (mol.) biology,
Systems • soil, plant, animal
• construction
• trade analysis
Valorisation Sustainable? Conversion
• food, feed • process tech
• fiber, • biotechnology
• fuel
History – Successors of CoBioTech
€24m
€10m + €6m
2006 2015
€28m + €17m
€10m + €11m + €17m + €14m + €15m + €14m + €??m
2008 1+ 2016
2€13m + €10m
2012 189,000,000 € 2014
From SRA – Systems Biology in Europe 2016:
Our objectives
Use synergies between current mechanisms of biotechnology research
funding in Europe
to highlight the benefits of a bio-based economy for society, and thus
to maintain and strengthen Europe’s global lead in modern
biotechnology.
Bundling three predecessor ERA-Nets in the area of biotechnology
significantly increases public funding (call volume ~ 36 Mio €),
intensifies collaboration across relevant sectors and countries, thus
advancing RD&I in industrial biotechnology
establishing systems and synthetic biology as technology
drivers in applied biotechnology, and
enhancing the potential for exploitation through active industry
involvement.Who are we?
JUELICH DE
BMBF DE
FNR DE
MIZS SI
FCT PT
MINECO ES
SMWK DE
BBSRC UK
MINCYT AR 22 partners
SPW BE +
ANR FR
3 observers
ADECAL NC
CSO/MOH IL
NWO NL
RCN NO
UEFISCDI RO
TUBITAK TR
VIAA LV
NCBR PL
ETAg EE
MIUR IT
CDTI ES
Dec. 1, 2016 – Nov. 30, 2021
CTI CH
FASIE RU
NSF USThe co-funded call will focus on application-oriented research in Envisaged call opening: December 1, 2016 Synthetic biology approaches to design and construct new biological parts, devices and systems Systems biology approaches to metabolic engineering and optimisation of biological processes Identification and use of the metabolic potentials of genomic data Chemical and biotechnological approaches to transform bio-based molecules into molecules with high added value.
The co-funded call: evaluation criteria Pre-Proposals (5 pages) Relevance to the scope of the call Excellence Impact Full Proposals (30 pages) Excellence Impact Implementation
Funding
Call volume Country
(up to €mio)
BMBF/JUELICH DE 9.00
FNR DE 2.00
MIZS SI 0.63
MINECO ES 1.00
SMWK DE 1.00
BBSRC UK 2.62
MINCYT AR 0.50
SPW BE 1.00
ANR FR 1.50
CSO/MOH IL 0.30
NWO NL 1.00
RCN NO 1.50
UEFISCDI RO 0.50
TUBITAK TR 1.00
VIAA LV 0.30
NCBR PL 0.70
ETAg EE 0.10
MIUR IT 0.40
CDTI ES 0.53
CTI CH 1.5
FASIE RU 1.0
Sum national contr. ~ 28 €mio
EU-Top Up * 8.7 €mio
Total Call Volume 36.7 €mioPre-Announcement published
Deadline for PP-Submission Eligibility check webconf
(March 3, 2017)
Call Opening
(Dec 1, 2016) PP-Submission kjfdsfeoiurzoewrzvezrb
Eligibility check
ouvlisionewrivzeoutibz
evrouewtzewotvuoiewo
uzvboiewtetuoitvVEUOI
TEWOIOFGNVEWZHO
IUPEOIURPEOTURITJ
OHOSHGPPOJXYPVO
JY
Ineligible PP
STEP 1
excluded
Ranked PP‘s
kjfdsfeoiurzoewrzvezrb
ouvlisionewrivzeoutibze
vrouewtzewotvuoiewou
zvboiewtetuoitvVEUOIT
EWOIOFGNVEWZHOI
UPEOIURPEOTURITJ
OHOSHGPPOJXYPVO
JY
IEP-Evaluation-Meeting PP-Remote-Evaluation
Selection of PP for step 2
Deadline for FP-Submission
(July 20, 2017)
FP-Submission
Step 2: Full Proposals kjfdsfeoiurzoewrzvezrbouvlisio
Mid/End May 2017 newrivzeoutibzevrouewtzewotv
uoiewouzvboiewtetuoitvVEUOI
TEWOIOFGNVEWZHOIUPEOI
URPEOTURITJOHOSHGPPO
JXYPVOJY
FP-Remote-Evaluation
Communication to applicants
STEP 2
Selection of projects
Ranked FP‘s
Communication to applicants IEP-Meeting
(Mid/End Oct, 2017)
National negotiations Project start
December 2017 - May 2018Additional joint funding activities (without EC co-funding)
Advance RD&I in industrial biotechnology in line with the Strategic
Agenda and the outcomes of the "European Biotechnology Hub."
Depending on the availability of funds, one funding activity per year (up
to four funding activities after the co-funded call)
calls for research projects
scientific knowledge hubs
mobility awards
prizes
measures for capacity building etc..European Biotechnology Hub - Objectives
Integrate actors from all parts of biotechnology value chains and
from all relevant scientific areas and industry sectors
policy actors,
strategic European Instruments & Initiatives
scientific and industrial actors
Provide one central umbrella to
biotechnology-relevant activities
for Europe and beyond
(e.g. EC, ERA-Nets, JTIs, PPP, KICs,
PLATFORM)Biotech Hub Meetings What happens? Presenting and discussing of strategic issues, challenges, activities Exchange of experiences regarding different and common actions of ERA-Nets and other strategic European instruments and initiatives in related areas Outcome Exchange of knowledge, „best practice“, experiences regarding regional, national and European actions and strategies Networks and collaborations are enlarged or strengthened Topics for future ERA-Nets (or additional calls) or ideas for other forms of ollaboration between policy makers and funding bodies Recommendations to the EC
Biotech Hub Workshops Who? scientific and industrial actors What happens? Training Ideas, demands, concepts are discussed/developed Networks are made or strengthened Outcome Better understanding of other stakeholders‘ demands and ways of working Newly developed consortia and project ideas New knowledge and skills, e.g. regarding European collaboration
Strategic Research and Innovation Agenda (SRIA)
maximise the long term benefit of bringing together 3 previously
separate ERA-Nets to achieve the goals of:
speeding up research and innovation in industrial
biotechnology
establishing systems biology and synthetic biology as
technology drivers while focusing on downstream industrial
applications
Shared vision, identifying areas
where synthetic biology,
systems biology, and industrial
biotechnology can be aligned to
have the most impactStrategic Research and Innovation Agenda (SRIA) Strategic Connections (Identification and mapping of existing relevant national, EU, international initiatives and infrastructure). Strategic workshops -> The strategic agenda will describe: areas of strategic importance between the three previous ERA-Nets, where there is added value in advancing those areas through transnational activities the extent of coordination at that time which will serve as a baseline indicator against which increases in coordination and cooperation can be measured a mutually agreed (and realistic) understanding of what CoBioTech can achieve
Negative public perception Risk of negative public perception (combined with a lack of knowledge, e.g. „gene technology“ / „green biotechnology“)
Strategic Research and Innovation Agenda (SRIA) Expectations and a best practice RRI framework develop bespoke expectations and best practice RRI framework integrate the uptake of these guidelines into funding assessment require funded projects to report against the expectations set out in the RRI best practice framework Training of scientists Communication
The co-funded call: timeline and proposals Website: www.cobiotech.eu Contact: Dr. Petra E. Schulte/ Dr. Christian Breuer Project Management Jülich (JUELICH) Division Bioecomony Department European Initiatives, International Affairs (BIO7) Forschungszentrum Jülich GmbH petra.schulte@fz-juelich.de +(0)49 2461 61 9031 Call Office (ptj-cobiotech@fz-juelich.de) Submission Website (http://www.submission-cobiotech.eu/)
You can also read
